| Code | CSB-MP012365HU1 |
| Abbreviation | Recombinant Human KIR3DL2 protein, partial (Active) |
| MSDS | |
| Size | $9.9 |
| Promotion | |
| Order now | |
| Image |
|
| Have Questions? | Leave a Message or Start an on-line Chat |
KIR3DL2 functions as an inhibitory receptor on natural killer and T cells, recognizing HLA-A*03 and HLA-A*11 alleles to modulate immune surveillance in cancer and autoimmune contexts. This mammalian-expressed construct spanning residues 22–340 captures the three extracellular immunoglobulin-like domains essential for HLA engagement, and its native glycosylation pattern supports conformationally authentic ligand recognition. Functional ELISA validation demonstrates specific antibody binding with an EC50 of 14.18–23.93 ng/mL, providing quantitative evidence that this protein maintains epitope accessibility required for therapeutic antibody screening, competitive inhibition assays, and epitope mapping studies. The combination of >90% purity and <1.0 EU/μg endotoxin meets the quality thresholds commonly required for surface plasmon resonance affinity characterization, biolayer interferometry kinetic analysis, and receptor-ligand interaction profiling in immune checkpoint research.
There are currently no reviews for this product.